Cargando…

Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)

OBJECTIVE: We assessed trabectedin in patients with advanced uterine leiomyosarcoma (uLMS) in real-life clinical practice given according to the marketing authorization. METHODS: Thirty-six women from 11 tertiary hospitals across Spain who received trabectedin after anthracycline-containing regimen/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rubio, María Jesús, Lecumberri, María José, Varela, Silvia, Alarcón, Jesús, Ortega, María Eugenia, Gaba, Lydia, Espinós, Jaime, Calzas, Julia, Barretina, Pilar, Ruiz, Isabel, Marquina, Gloria, Santaballa, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296187/ https://www.ncbi.nlm.nih.gov/pubmed/32566719 http://dx.doi.org/10.1016/j.gore.2020.100594

Ejemplares similares

SEOM-GEICO clinical guidelines on endometrial cancer (2021)
por: Barretina-Ginesta, María Pilar, et al.
Publicado: (2022)

Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study
por: Yubero, Alfonso, et al.
Publicado: (2022)

Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin
por: Amant, Frédéric, et al.
Publicado: (2015)

Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report
por: Bongiovanni, Alberto, et al.
Publicado: (2015)

Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network
por: López-Guerrero, José Antonio, et al.
Publicado: (2022)

The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer—A GEICO Study
por: Fernández-Serra, Antonio, et al.
Publicado: (2023)

Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program
por: Yubero, Alfonso, et al.
Publicado: (2023)

GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012
por: González Martín, A., et al.
Publicado: (2013)

Long-Lasting Response to Trabectedin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report
por: Nteli, Viktoria-Anna, et al.
Publicado: (2018)

Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
por: Garcia-Casado, Zaida, et al.
Publicado: (2022)

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
por: De Sanctis, Rita, et al.
Publicado: (2015)

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma
por: Gadducci, Angiolo, et al.
Publicado: (2018)

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma [Corrigendum]
Publicado: (2016)

GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer
por: Perez-Fidalgo, J Alejandro, et al.
Publicado: (2019)

Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022)

Trabectedin in Advanced High-Grade Uterine Leiomyosarcoma: A Case Report Illustrating the Value of (18)FDG-PET-CT in Assessing Treatment Response
por: Payne, M.J., et al.
Publicado: (2014)

Effect of the Combination of Trabectedin and Pegylated Liposomal Doxorubicin in a BRCA2 Mutation Carrier with Recurrent Platinum-Sensitive Ovarian Cancer
por: Rubio Pérez, María Jesús
Publicado: (2017)

Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)
por: Perez-Fidalgo, J.A., et al.
Publicado: (2021)

Case Report of Suspected Rhabdomyolysis during Treatment with Trabectedin in a Patient with Metastatic Leiomyosarcoma
por: Lamm, W., et al.
Publicado: (2010)

Metastasis of Uterine Leiomyosarcoma to the Breast: Medical and Histopathological Criteria
por: Colón, Eugenia
Publicado: (2020)

Long lasting response of trabectedin in patient with gastric leiomyosarcoma with liver metastasis: an update to previous report
por: Rastogi, Sameer, et al.
Publicado: (2019)

Trabectedin and Radiation Therapy for Cardiac Metastasis From Leiomyosarcoma: A Case Report and Review of the Literature
por: Tortorelli, Ilaria, et al.
Publicado: (2022)

Long-Term Progression-Free Survival in a Patient with Metastatic Leiomyosarcoma of the Inguinal Region Treated with Trabectedin
por: Haslbauer, Ferdinand
Publicado: (2018)

Long-Time Progression-Free Survival with Trabectedin in Chemorefractory Metastatic Leiomyosarcoma of the Retroperitoneum: A Case Report
por: Reichinger, Andreas
Publicado: (2023)

Nutrient intake in the GEICO multicenter trial: the effects of a multicomponent worksite intervention
por: Mishra, S, et al.
Publicado: (2013)

A Case of Renal Metastasis of Uterine Leiomyosarcoma
por: Bajic, Petar, et al.
Publicado: (2017)

Microvessels Density in Uterine Leiomyosarcoma
por: Bobiński, Marcin, et al.
Publicado: (2015)

Long-term response to first-line trabectedin in an elderly female patient with a metastatic leiomyosarcoma unfit for anthracycline
por: Maruzzo, Marco, et al.
Publicado: (2016)

The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma—A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
por: Pizarro, David, et al.
Publicado: (2023)

Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile
por: Astolfi, Annalisa, et al.
Publicado: (2020)

Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma
por: Lamm, Wolfgang, et al.
Publicado: (2014)

Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2011)

Potential Biomarker for Human Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2014)

Uterine leiomyosarcoma: A case report
por: Kaur, Khushpreet, et al.
Publicado: (2014)

Prevalence and occult rates of uterine leiomyosarcoma
por: Wang, Lingxiang, et al.
Publicado: (2020)

A Case Report Of Uterine Leiomyosarcoma
por: Cao, Siyu, et al.
Publicado: (2019)

The Role of Hedgehog Pathway in Uterine Leiomyosarcoma
por: Garcia, Natalia, et al.
Publicado: (2021)

Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)
por: Pérez-Fidalgo, Jose Alejandro, et al.
Publicado: (2023)

Perforated intestinal leiomyosarcoma as a metastasis of uterine leiomyosarcoma: a case report
por: Saylam, Barış, et al.
Publicado: (2009)

Cervical leiomyosarcoma in a teenage girl: A rare form of uterine leiomyosarcoma()
por: Adewole, Adebayo A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_36vf3tcc5ut9ti3p3vgb0pitpo